Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck
Yale University
Yale University
Massachusetts General Hospital
West China Hospital
Samsung Medical Center
West China Hospital
West China Hospital
Petrov, Andrey
University of Texas Southwestern Medical Center
West China Hospital
West China Hospital
West China Hospital
Dana-Farber Cancer Institute
University of Chicago
AHS Cancer Control Alberta
National Taiwan University Hospital
China Medical University Hospital
West China Hospital
Massachusetts General Hospital
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
University of California, Davis
National Health Research Institutes, Taiwan
Region Skane
German Cancer Research Center
OHSU Knight Cancer Institute
Instituto Nacional de Cancerologia de Mexico
Cambridge University Hospitals NHS Foundation Trust
SCRI Development Innovations, LLC
University College, London
Memorial Sloan Kettering Cancer Center
The Netherlands Cancer Institute
University Health Network, Toronto
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Qingdao Central Hospital
Yonsei University
Shanghai Pulmonary Hospital, Shanghai, China
Guangdong Association of Clinical Trials
Intergroupe Francophone de Cancerologie Thoracique
Shandong University
Universitätsklinikum Hamburg-Eppendorf
University of Washington
National Taiwan University Hospital
Vanderbilt-Ingram Cancer Center
Saint John's Cancer Institute
Shanghai Changzheng Hospital
UNICANCER
Chonnam National University Hospital
Peking University
Centre Leon Berard
H. Lee Moffitt Cancer Center and Research Institute
Guangdong Association of Clinical Trials